Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000252291 is a human gene that encodes a noncoding RNA belonging to the small nucleolar RNA (snoRNA) class, which are typically involved in guiding chemical modifications (such as methylation or pseudouridylation) of ribosomal RNA or other small nuclear RNAs[1]. snoRNAs function within the nucleolus and are not directly targeted by current therapeutic agents. There is no evidence supporting its direct involvement in disease or its suitability as a therapeutic target. In summary, ENSG00000252291 is a noncoding small nucleolar RNA gene, not a conventional protein, receptor, enzyme, or other typical therapeutic target[1]. There is no information supporting its use as a biomarker, its involvement in drug interactions, or its direct link to disease. If you require a canonical protein target or a molecule with known therapeutic associations, this entry may be insufficient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA, ENSG00000252291 (ENSG00000252291).